期刊
AMERICAN JOURNAL OF MEDICAL GENETICS
卷 115, 期 3, 页码 183-188出版社
WILEY-LISS
DOI: 10.1002/ajmg.10692
关键词
lung cancer; cytogenetic imbalances; genetic/epigenetic changes; tumor suppressor genes; oncogenes; molecular biomarkers
资金
- NCI NIH HHS [CA-06927, CA-58184] Funding Source: Medline
The development and progression of lung cancer is a multistep process characterized by the accumulation of numerous genetic and epigenetic alterations, some of which occur early in the course of disease. In this review, we summarize cytogenetic imbalances and molecular genetic/epigenetic changes seen in human small-cell and non-smallcell lung cancer. Alterations of tumor suppressor genes and oncogenes leading to perturbations of key cell-regulatory and growth-control pathways are highlighted. The translational implications of molecular biomarkers for risk assessment, early detection, and monitoring of chemoprevention trials are discussed. (C) 2002 Wiley-Liss, Inc.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据